Ocugen Inc
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
NG NovaGold Resources Inc
KRNLW Kernel Group Holdings Equity Warrants Exp 02 Feb 2026 *W EXP 02/02/2026
BRKHW BurTech Acquisition Equity Warrants Exp 18th Dec 2026 *W EXP 12/18/2026
UHALB Amerco
NACP.SO Impact Shares NAACP Minority Empowerment ETF
EDMCQ Education Management Corp
LBPWQ 4D pharma Equity Warrant Exp 22 Feb 2025 *W EXP 02/22/2025
MAAL Marketing Alliance Inc
AMC AMC Entertainment Holdings Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Ocugen, Inc. is a biopharmaceutical company focused on developing gene therapies to cure blindness diseases and developing vaccine for COVID-19. The Company's technology pipeline includes: COVID-19 Vaccine (0.5), Modifier Gene Therapy Platform and Novel Biologic Therapies for Retinal Diseases. COVID-19 Vaccine candidate is focused on developing, manufacturing and commercializing COVAXIN for the prevention of COVID-19 in humans in the Ocugen Covaxin Territory. COVAXIN is a whole-virion inactivated COVID-19 vaccine candidate and is formulated with the inactivated SARS-CoV-2 virus. The Modifier Gene Therapy platform is designed for retinal diseases, including retinitis pigmentosa (RP), leber congenital amaurosis (LCA) and dry age-related macular degeneration (AMD). It is developing OCU200, a biologic product candidate to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet AMD. OCU400, its first product candidate being developed with its modifier gene therapy platform.

Closing Price
$1.40
Day's Change
0.02 (1.45%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.44
Day's Low
1.36
Volume
(Below Average)
Volume:
2,964,050

10-day average volume:
3,656,177
2,964,050
  • Prev Close
    1.38
  • Today's Open
    1.43
  • Day's Range
    1.36-1.44
  • Avg Vol (10-day)
    3.7M
  • Last (time)
    3:59p ET 12/08/22
  • Last (size)
    18
  • 52-Wk Range
    1.32 - 6.50
    LowHigh
  • (12/09/21 - 12/07/22)
    6.06%
  • 102.3%
  • Market Cap
    308.6M
  • Shares Outstanding
    218.9M
  • -0.35
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 4.0
  • 34.90
  • (% of float 11/15/22)
    19.27

Latest News

December 08, 2022
5:26 pm ET
MarketWatch
December 07, 2022
5:25 pm ET
MarketWatch
8:00 am ET
Globe Newswire
December 06, 2022
5:26 pm ET
MarketWatch
December 05, 2022
5:25 pm ET
MarketWatch
December 02, 2022
5:25 pm ET
MarketWatch
December 01, 2022
5:24 pm ET
MarketWatch
November 29, 2022
5:25 pm ET
MarketWatch
November 28, 2022
5:24 pm ET
MarketWatch
7:30 am ET
Globe Newswire
November 23, 2022
5:14 pm ET
MarketWatch
November 22, 2022
5:14 pm ET
MarketWatch
November 21, 2022
5:14 pm ET
MarketWatch
November 18, 2022
5:14 pm ET
MarketWatch
November 17, 2022
5:14 pm ET
MarketWatch
November 16, 2022
5:14 pm ET
MarketWatch
November 15, 2022
5:14 pm ET
MarketWatch
November 14, 2022
5:14 pm ET
MarketWatch
November 11, 2022
5:14 pm ET
MarketWatch
November 09, 2022
5:14 pm ET
MarketWatch
November 08, 2022
7:30 am ET
Globe Newswire
November 07, 2022
5:14 pm ET
MarketWatch
November 04, 2022
5:14 pm ET
MarketWatch
November 03, 2022
5:14 pm ET
MarketWatch
November 02, 2022
5:14 pm ET
MarketWatch
November 01, 2022
5:14 pm ET
MarketWatch
October 31, 2022
5:14 pm ET
MarketWatch
October 27, 2022
5:14 pm ET
MarketWatch
7:30 am ET
Globe Newswire
October 24, 2022
5:15 pm ET
MarketWatch
October 21, 2022
5:14 pm ET
MarketWatch
October 20, 2022
5:14 pm ET
MarketWatch
October 19, 2022
5:14 pm ET
MarketWatch
7:30 am ET
Globe Newswire
October 18, 2022
5:14 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.